NAMPT inhibition was shown to mediate this additional anticancer benefit by i) NAD-mediated inhibition of the cisplatin-induced SASP in epithelial ovarian cancer and ii) suppression of the platinum-induced senescence-associated cancer stem cells [139]. Here, NAMPT is linked to cancer.